Aa Aa Aa
  • Investor Information Overview

Corporate Profile
Sucampo Pharmaceuticals, Inc. is a publicly traded (NASDAQ: SCMP) global biopharmaceutical company focused on innovative research, discovery, development and commercialization of proprietary drugs to treat gastrointestinal, ophthalmic, neurologic, and oncology-based inflammatory disorders, and are also considering o  More >>
Stock Quote
SCMP (Common Stock)
ExchangeNASDAQ GM (US Dollar)
Change (%) Stock is Up 0.02 (0.15%)
Data as of 12/18/14 4:00 p.m. ET
Refresh quote
Recent NewsRSS   | More >>
12/15/14Sucampo Appoints John H. Johnson to Board of DirectorsPrinter Friendly Version
11/25/14Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 26th Annual Piper Jaffray Healthcare ConferencePrinter Friendly Version
11/12/14Sucampo Files Patent Infringement Lawsuit Against Dr. Reddy'sPrinter Friendly Version
11/11/14Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the Stifel 2014 Healthcare ConferencePrinter Friendly Version
Upcoming Events
There are currently no events scheduled.
Quotes delayed at least 15 minutes. Market data provided by Interactive Data.

Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions.